MPR Weekly Dose 132 — Social Media Warning; Cisplatin-Associated Ototoxicity Tx; New Cerebral Adrenoleukodystrophy Tx; MRI Contrast Agent; Generic Tazorac
This week we go over warnings about a new social media challenge; treatment approvals in cisplatin-associated ototoxicity, cerebral adrenoleukodystrophy, MRI contrast agents and a generic version of t...
23 Sep 202213min
MPR Weekly Dose 131 — Approvals in Plaque Psoriasis, Hepatorenal Syndrome and Neutropenia; Priority Review for Rett Syndrome Therapy; Multivitamins Assessed in Cognition
Approvals in psoriasis, hepatorenal syndrome, and neutropenia; novel therapy gains Priority Review for Rett Syndrome; and the effects of multivitamin supplementation assessed on cognitive function.
16 Sep 202213min
MPR Weekly Dose 130 — FDA Vote on ALS Treatment; CPAP, BiPAP Recall; CRISPR Therapy for Hereditary Angioedema; Imfinzi Approved for Biliary Tract Cancer; Spevigo Approved
Hello listener and welcome to episode 130 of the MPR Weekly Dose Podcast. This week we have news of the FDA's vote on an ALS treatment; CPAP and BiPAP device recalls; Orphan Drug designation for a nov...
9 Sep 202213min
MPR Weekly Dose 129 — Omicron-Adapted Booster Dose; Influenza Season Guidance; Nirmatrelvir Efficacy; DEA Warn Over "Rainbow Fentanyl"; Chronic Idiopathic Constipation Tx
Omicron-adapted COVID-19 booster vaccines; guidance for the 2022-23 influenza season; efficacy of COVID-19 antiviral; 'rainbow fentanly' targeting youth; and a device to treat chronic idiopathic const...
1 Sep 202215min
MPR Weekly Dose 128 — USPSTF Statin Recommendations; At-Home Visual Test; Novel MDD Treatment; Novavax Authorized in Adolescents; FDA Fecal Microbiota Transplant Alert
USPSTF recommendations on the use of statins for primary prevention of cardiovascular disease; At-home visual acuity test; A new treatment for major depressive disorder; Novavax COVID-19 vaccine appro...
26 Aug 202214min
MPR Weekly Dose 127 — Novavax Booster; OTC Hearing Aids; Combo Prostate Cancer Tx; First Gene Therapy for Beta-Thalassemia; Repeat At-Home COVID-19 Testing Needed
Novavax vaccine booster update; over-the-counter hearing aids; priority review for a castration-resistant prostate cancer combination treatment; a first gene therapy approved for beta-thalassemia; FDA...
19 Aug 202214min
MPR Weekly Dose 126 — Change to Monkeypox Vaccine Supply; Myfembree Indication Expanded; Amazon Among Companies to Receive FDA Warning; Impurity in Diabetes Tx
New authorization for intradermal administration of monkeypox vaccine; a new approval for endometriosis pain; Amazon is among the companies to receive an FDA Warning Letter for selling unapproved drug...
11 Aug 202210min
MPR Weekly Dose 125 — Device Cleared to Treat C-Section Pain; Plaque Psoriasis Cream; Contrast Agent Shortage Addressed; Lucentis Biosimilar Approved; OTC Laxative Recall Expanded
A neurostimulation device has been cleared for post-C-section pain; a new plaque psoriasis treatment; the FDA address the contrast agent shortage; Lucentis biosimilar treatment is approved; and the re...
5 Aug 202211min
